The Pharma Industry is Fighting Against COVID-19
Yale SOM alumni Nandish Poluru discusses how the pharma industry is fighting against COVID-19 – the pharma industry’s cooperative efforts to treat and prevent COVID-19.
The head of the technology team for global clinical development at Bristol Myers Squibb and with industry experience of almost two decades, Nandish Poluru explains that his team is responsible for all aspects of the technology, digital, and data strategy to ensure the overall delivery, support, and reliable operations of clinical trials.
Along with various other technology teams within the company, his team identified the processes and technological capabilities required to expedite COVID research, including clinical operations capabilities and patient recruitment capabilities, as well as the platform that is required for electronic data capture once a study enrolls patients. The pharma industry is collaborating to fight COVID-19 in many ways.
Related Posts
Using Blockchain to Tip Farmers Might Backfire
Yale SOM’s Saed Alizamir, warns about an unexpected eventuality that stems from customers using apps that use blockchain to tip farmers.
Is Remote Work Capable of Controlling Inflation?
This Chicago Booth Review article examines the possibility that remote work could hold the potential of controlling inflation.
The Secret Behind Stock Prices Falling in Tandem
New research by Yale SOM’s Heather Tookes and colleagues suggest a relationship between margin trading and stock prices falling together.
Which Companies’ Stocks are “Immune” to the Pandemic?
A new working paper co-authored by Berkeley Haas Prof. Ross Levine identifies why some companies are less affected by the pandemic.
Stocks Rise While COVID-19 Cases Rise Too
Preliminary research by Yale SOM’s Peter Schott, the Juan Trippe Professor of International Economics, and three co-authors, reveals that unexpected investor behavior is causing the stock market to recover while COVID-19 cases are on the rise.
The What, How, and Why of Stock Market Crashes
Yale SOM’s Robert Shiller examines how the stock market rise of the 1920s, the crash of 1929, and the Great Depression that followed came to be seen as a tale of recklessness and divine punishment—and how that narrative still shapes our understanding of the stock market, in his new book – NARRATIVE ECONOMICS: How Stories Go Viral and Drive Major Economic Events
